LLP2A alendronate
LLP2A阿仑膦酸钠
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameLLP2A alendronate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of CaliforniaCalifornia Institute Regenerative Med
Inactive CompaniesCalifornia Institute For Regenerative Medicine
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A